Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing

Stockhouse May 30 10:00

Spectral Medical Q1 Loss Widens, Says Tigris Trial Enrollment Reaches 106 Patients

Spectral Medical (EDT.TO) said its first quarter loss significantly widened due to higher operating expense. The company, which is developing therapies to treat sepsis, recorded a loss of $4.2 million

MT NewswiresMay 13 08:09

Spectral Medical Brief: Loss for the Three-months Ended March 31, 2024 Was $4,160,000 ($0.01 per Share)

07:34 AM EDT, 05/13/2024 (MT Newswires) -- Spectral Medical Brief: Loss for the three-months ended March 31, 2024 was $4,160,000 ($0.01 per share)

MT NewswiresMay 13 06:34

Spectral Medical Announces First Quarter Results and Provides Corporate Update

Stockhouse May 13 06:30

Spectral Medical Inc. Announces C$8.5 Million Bought Deal Convertible Note Financing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES

GlobeNewswireMay 9 13:34

Spectral Medical Brief: Providing April Tigris Trial Update; 105 Patients Enrolled; Says April Represents a Record Breaking Month for Patient Enrollment

07:31 AM EDT, 05/06/2024 (MT Newswires) -- Spectral Medical Brief: Providing April Tigris Trial Update; 105 patients enrolled; Says April represents a record breaking month for patient enrollment

MT NewswiresMay 6 06:31